1-2 of 2
Martina Kerz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Dohner, MD, Martina Kerz, Francisco del Valle, MD, Björn Heydrich, MD, Ingo Schmidt-Wolf, MD, Hans Pralle, MD, Katharina Götze, MD, Elisabeth Koller, MD, David Nachbaur, MD, Hans G. Mergenthaler, MD, Walter Fiedler, MD, Detlef Haase, MD, Stephan Kremers, MD, Matthias Theobald, MD, Axel Matzdorff, MD, Arnold Ganser, MD, Hartmut Dohner, MD
Journal: Blood
Blood (2006) 108 (11): 1949.
https://doi.org/10.1182/blood.V108.11.1949.1949
Published: 2006
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Doehner, MD, Martina Kerz, Frank Hartmann, MD, Francesco del Valle, MD, Axel Glasmacher, MD, Hans Pralle, MD, Katharina Goetze, MD, Elisabeth Koller, MD, Guenther Gastl, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stephan Kremers, MD, Christoph Nerl, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Doehner, MD, for the German-Austrian, AML Study Group (AMLSG)
Journal: Blood
Blood (2005) 106 (11): 1849.
https://doi.org/10.1182/blood.V106.11.1849.1849
Published: 2005